ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=588850, encodeId=724d58885043, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12月初投稿，赶上圣诞但还是在1.7收到一审意见，2个外审评委意见都很好，其中一个给了两个实验建议，另一个评委只指出几处文字问题。2.20一审投回后，两周后即3.5日收到评委的接受回信，给了几处格式修改要求。3.18投回后，3.19正式接受，两周多后4.9号看到文章的在线online。及时三个月多点，取决于一审意见和补实验的周期，AHA.的工作效率是很高的，杂志社也很nice，有问题直接发邮件，都会有回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=734, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45db5217374, createdName=147718f9m15暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578623, encodeId=9b705e86234c, content=审稿速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567501, encodeId=e2cb56e5015c, content=审稿速度非常块，1月就有一审的意见。三个评委提了很多专业问题，给了90天时间修回。二审之快让我吃惊，二周后无任何修改直接接受，然后是二周就出样稿并网站发布。这可以说这几年经历的最快的发表速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555808, encodeId=e1445558080a, content=一般般吧.不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e502075746, createdName=营养医师, createdTime=Mon May 07 19:09:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544291, encodeId=79125442918a, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833201, encodeId=7abf83320174, content=这个杂志不错，投了一篇，给人的感觉就是，专业高效。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Fri Aug 19 10:52:21 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521784, encodeId=b149521e84e0, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常好的杂志但是很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cf91708365, createdName=Lixin Jia, createdTime=Wed Apr 27 14:25:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517401, encodeId=fdfa51e401c5, content=即时IF3266/669=4.882，欢迎明年回归5-6分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sun Dec 06 21:51:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485290, encodeId=5d7a485290bf, content=从居稿件，到大修，到小修，到接受，历时一年多，收益很多，不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Nov 04 21:21:00 CST 2011, time=2011-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472906, encodeId=1dd74e2906e7, content=我是试投了一篇关于血脂和amyloidosis方面的文章，写了大约半年。投出去不到3天被拒。估计是可能对amyloid方面不是很感兴趣。拒稿倒是很快。有关与动脉硬化方面的文章还可能试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=744, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老王, createdTime=Fri Dec 10 13:34:00 CST 2010, time=2010-12-10, status=1, ipAttribution=)]

2020-04-14 147718f9m15暂无昵称

审稿速度:1.0 | 投稿命中率:25.0
经验分享：12月初投稿，赶上圣诞但还是在1.7收到一审意见，2个外审评委意见都很好，其中一个给了两个实验建议，另一个评委只指出几处文字问题。2.20一审投回后，两周后即3.5日收到评委的接受回信，给了几处格式修改要求。3.18投回后，3.19正式接受，两周多后4.9号看到文章的在线online。及时三个月多点，取决于一审意见和补实验的周期，AHA.的工作效率是很高的，杂志社也很nice，有问题直接发邮件，都会有回复。

734 0

[GetPortalCommentsPageByObjectIdResponse(id=588850, encodeId=724d58885043, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12月初投稿，赶上圣诞但还是在1.7收到一审意见，2个外审评委意见都很好，其中一个给了两个实验建议，另一个评委只指出几处文字问题。2.20一审投回后，两周后即3.5日收到评委的接受回信，给了几处格式修改要求。3.18投回后，3.19正式接受，两周多后4.9号看到文章的在线online。及时三个月多点，取决于一审意见和补实验的周期，AHA.的工作效率是很高的，杂志社也很nice，有问题直接发邮件，都会有回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=734, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45db5217374, createdName=147718f9m15暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578623, encodeId=9b705e86234c, content=审稿速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567501, encodeId=e2cb56e5015c, content=审稿速度非常块，1月就有一审的意见。三个评委提了很多专业问题，给了90天时间修回。二审之快让我吃惊，二周后无任何修改直接接受，然后是二周就出样稿并网站发布。这可以说这几年经历的最快的发表速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555808, encodeId=e1445558080a, content=一般般吧.不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e502075746, createdName=营养医师, createdTime=Mon May 07 19:09:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544291, encodeId=79125442918a, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833201, encodeId=7abf83320174, content=这个杂志不错，投了一篇，给人的感觉就是，专业高效。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Fri Aug 19 10:52:21 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521784, encodeId=b149521e84e0, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常好的杂志但是很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cf91708365, createdName=Lixin Jia, createdTime=Wed Apr 27 14:25:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517401, encodeId=fdfa51e401c5, content=即时IF3266/669=4.882，欢迎明年回归5-6分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sun Dec 06 21:51:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485290, encodeId=5d7a485290bf, content=从居稿件，到大修，到小修，到接受，历时一年多，收益很多，不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Nov 04 21:21:00 CST 2011, time=2011-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472906, encodeId=1dd74e2906e7, content=我是试投了一篇关于血脂和amyloidosis方面的文章，写了大约半年。投出去不到3天被拒。估计是可能对amyloid方面不是很感兴趣。拒稿倒是很快。有关与动脉硬化方面的文章还可能试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=744, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老王, createdTime=Fri Dec 10 13:34:00 CST 2010, time=2010-12-10, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

审稿速度挺快的

978 0

[GetPortalCommentsPageByObjectIdResponse(id=588850, encodeId=724d58885043, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12月初投稿，赶上圣诞但还是在1.7收到一审意见，2个外审评委意见都很好，其中一个给了两个实验建议，另一个评委只指出几处文字问题。2.20一审投回后，两周后即3.5日收到评委的接受回信，给了几处格式修改要求。3.18投回后，3.19正式接受，两周多后4.9号看到文章的在线online。及时三个月多点，取决于一审意见和补实验的周期，AHA.的工作效率是很高的，杂志社也很nice，有问题直接发邮件，都会有回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=734, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45db5217374, createdName=147718f9m15暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578623, encodeId=9b705e86234c, content=审稿速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567501, encodeId=e2cb56e5015c, content=审稿速度非常块，1月就有一审的意见。三个评委提了很多专业问题，给了90天时间修回。二审之快让我吃惊，二周后无任何修改直接接受，然后是二周就出样稿并网站发布。这可以说这几年经历的最快的发表速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555808, encodeId=e1445558080a, content=一般般吧.不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e502075746, createdName=营养医师, createdTime=Mon May 07 19:09:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544291, encodeId=79125442918a, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833201, encodeId=7abf83320174, content=这个杂志不错，投了一篇，给人的感觉就是，专业高效。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Fri Aug 19 10:52:21 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521784, encodeId=b149521e84e0, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常好的杂志但是很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cf91708365, createdName=Lixin Jia, createdTime=Wed Apr 27 14:25:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517401, encodeId=fdfa51e401c5, content=即时IF3266/669=4.882，欢迎明年回归5-6分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sun Dec 06 21:51:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485290, encodeId=5d7a485290bf, content=从居稿件，到大修，到小修，到接受，历时一年多，收益很多，不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Nov 04 21:21:00 CST 2011, time=2011-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472906, encodeId=1dd74e2906e7, content=我是试投了一篇关于血脂和amyloidosis方面的文章，写了大约半年。投出去不到3天被拒。估计是可能对amyloid方面不是很感兴趣。拒稿倒是很快。有关与动脉硬化方面的文章还可能试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=744, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老王, createdTime=Fri Dec 10 13:34:00 CST 2010, time=2010-12-10, status=1, ipAttribution=)]

2019-03-02 drCHD

审稿速度非常块，1月就有一审的意见。三个评委提了很多专业问题，给了90天时间修回。二审之快让我吃惊，二周后无任何修改直接接受，然后是二周就出样稿并网站发布。这可以说这几年经历的最快的发表速度。

569 0

[GetPortalCommentsPageByObjectIdResponse(id=588850, encodeId=724d58885043, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12月初投稿，赶上圣诞但还是在1.7收到一审意见，2个外审评委意见都很好，其中一个给了两个实验建议，另一个评委只指出几处文字问题。2.20一审投回后，两周后即3.5日收到评委的接受回信，给了几处格式修改要求。3.18投回后，3.19正式接受，两周多后4.9号看到文章的在线online。及时三个月多点，取决于一审意见和补实验的周期，AHA.的工作效率是很高的，杂志社也很nice，有问题直接发邮件，都会有回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=734, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45db5217374, createdName=147718f9m15暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578623, encodeId=9b705e86234c, content=审稿速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567501, encodeId=e2cb56e5015c, content=审稿速度非常块，1月就有一审的意见。三个评委提了很多专业问题，给了90天时间修回。二审之快让我吃惊，二周后无任何修改直接接受，然后是二周就出样稿并网站发布。这可以说这几年经历的最快的发表速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555808, encodeId=e1445558080a, content=一般般吧.不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e502075746, createdName=营养医师, createdTime=Mon May 07 19:09:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544291, encodeId=79125442918a, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833201, encodeId=7abf83320174, content=这个杂志不错，投了一篇，给人的感觉就是，专业高效。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Fri Aug 19 10:52:21 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521784, encodeId=b149521e84e0, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常好的杂志但是很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cf91708365, createdName=Lixin Jia, createdTime=Wed Apr 27 14:25:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517401, encodeId=fdfa51e401c5, content=即时IF3266/669=4.882，欢迎明年回归5-6分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sun Dec 06 21:51:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485290, encodeId=5d7a485290bf, content=从居稿件，到大修，到小修，到接受，历时一年多，收益很多，不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Nov 04 21:21:00 CST 2011, time=2011-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472906, encodeId=1dd74e2906e7, content=我是试投了一篇关于血脂和amyloidosis方面的文章，写了大约半年。投出去不到3天被拒。估计是可能对amyloid方面不是很感兴趣。拒稿倒是很快。有关与动脉硬化方面的文章还可能试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=744, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老王, createdTime=Fri Dec 10 13:34:00 CST 2010, time=2010-12-10, status=1, ipAttribution=)]

2018-05-07 营养医师

一般般吧.不难

327 0

[GetPortalCommentsPageByObjectIdResponse(id=588850, encodeId=724d58885043, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12月初投稿，赶上圣诞但还是在1.7收到一审意见，2个外审评委意见都很好，其中一个给了两个实验建议，另一个评委只指出几处文字问题。2.20一审投回后，两周后即3.5日收到评委的接受回信，给了几处格式修改要求。3.18投回后，3.19正式接受，两周多后4.9号看到文章的在线online。及时三个月多点，取决于一审意见和补实验的周期，AHA.的工作效率是很高的，杂志社也很nice，有问题直接发邮件，都会有回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=734, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45db5217374, createdName=147718f9m15暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578623, encodeId=9b705e86234c, content=审稿速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567501, encodeId=e2cb56e5015c, content=审稿速度非常块，1月就有一审的意见。三个评委提了很多专业问题，给了90天时间修回。二审之快让我吃惊，二周后无任何修改直接接受，然后是二周就出样稿并网站发布。这可以说这几年经历的最快的发表速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555808, encodeId=e1445558080a, content=一般般吧.不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e502075746, createdName=营养医师, createdTime=Mon May 07 19:09:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544291, encodeId=79125442918a, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833201, encodeId=7abf83320174, content=这个杂志不错，投了一篇，给人的感觉就是，专业高效。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Fri Aug 19 10:52:21 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521784, encodeId=b149521e84e0, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常好的杂志但是很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cf91708365, createdName=Lixin Jia, createdTime=Wed Apr 27 14:25:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517401, encodeId=fdfa51e401c5, content=即时IF3266/669=4.882，欢迎明年回归5-6分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sun Dec 06 21:51:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485290, encodeId=5d7a485290bf, content=从居稿件，到大修，到小修，到接受，历时一年多，收益很多，不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Nov 04 21:21:00 CST 2011, time=2011-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472906, encodeId=1dd74e2906e7, content=我是试投了一篇关于血脂和amyloidosis方面的文章，写了大约半年。投出去不到3天被拒。估计是可能对amyloid方面不是很感兴趣。拒稿倒是很快。有关与动脉硬化方面的文章还可能试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=744, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老王, createdTime=Fri Dec 10 13:34:00 CST 2010, time=2010-12-10, status=1, ipAttribution=)]

2017-07-16 13805560183

赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦

278 0

[GetPortalCommentsPageByObjectIdResponse(id=588850, encodeId=724d58885043, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12月初投稿，赶上圣诞但还是在1.7收到一审意见，2个外审评委意见都很好，其中一个给了两个实验建议，另一个评委只指出几处文字问题。2.20一审投回后，两周后即3.5日收到评委的接受回信，给了几处格式修改要求。3.18投回后，3.19正式接受，两周多后4.9号看到文章的在线online。及时三个月多点，取决于一审意见和补实验的周期，AHA.的工作效率是很高的，杂志社也很nice，有问题直接发邮件，都会有回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=734, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45db5217374, createdName=147718f9m15暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578623, encodeId=9b705e86234c, content=审稿速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567501, encodeId=e2cb56e5015c, content=审稿速度非常块，1月就有一审的意见。三个评委提了很多专业问题，给了90天时间修回。二审之快让我吃惊，二周后无任何修改直接接受，然后是二周就出样稿并网站发布。这可以说这几年经历的最快的发表速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555808, encodeId=e1445558080a, content=一般般吧.不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e502075746, createdName=营养医师, createdTime=Mon May 07 19:09:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544291, encodeId=79125442918a, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833201, encodeId=7abf83320174, content=这个杂志不错，投了一篇，给人的感觉就是，专业高效。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Fri Aug 19 10:52:21 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521784, encodeId=b149521e84e0, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常好的杂志但是很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cf91708365, createdName=Lixin Jia, createdTime=Wed Apr 27 14:25:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517401, encodeId=fdfa51e401c5, content=即时IF3266/669=4.882，欢迎明年回归5-6分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sun Dec 06 21:51:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485290, encodeId=5d7a485290bf, content=从居稿件，到大修，到小修，到接受，历时一年多，收益很多，不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Nov 04 21:21:00 CST 2011, time=2011-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472906, encodeId=1dd74e2906e7, content=我是试投了一篇关于血脂和amyloidosis方面的文章，写了大约半年。投出去不到3天被拒。估计是可能对amyloid方面不是很感兴趣。拒稿倒是很快。有关与动脉硬化方面的文章还可能试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=744, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老王, createdTime=Fri Dec 10 13:34:00 CST 2010, time=2010-12-10, status=1, ipAttribution=)]

2016-08-19 ms9532643183630560

这个杂志不错，投了一篇，给人的感觉就是，专业高效。

77 0

[GetPortalCommentsPageByObjectIdResponse(id=588850, encodeId=724d58885043, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12月初投稿，赶上圣诞但还是在1.7收到一审意见，2个外审评委意见都很好，其中一个给了两个实验建议，另一个评委只指出几处文字问题。2.20一审投回后，两周后即3.5日收到评委的接受回信，给了几处格式修改要求。3.18投回后，3.19正式接受，两周多后4.9号看到文章的在线online。及时三个月多点，取决于一审意见和补实验的周期，AHA.的工作效率是很高的，杂志社也很nice，有问题直接发邮件，都会有回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=734, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45db5217374, createdName=147718f9m15暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578623, encodeId=9b705e86234c, content=审稿速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567501, encodeId=e2cb56e5015c, content=审稿速度非常块，1月就有一审的意见。三个评委提了很多专业问题，给了90天时间修回。二审之快让我吃惊，二周后无任何修改直接接受，然后是二周就出样稿并网站发布。这可以说这几年经历的最快的发表速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555808, encodeId=e1445558080a, content=一般般吧.不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e502075746, createdName=营养医师, createdTime=Mon May 07 19:09:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544291, encodeId=79125442918a, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833201, encodeId=7abf83320174, content=这个杂志不错，投了一篇，给人的感觉就是，专业高效。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Fri Aug 19 10:52:21 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521784, encodeId=b149521e84e0, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常好的杂志但是很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cf91708365, createdName=Lixin Jia, createdTime=Wed Apr 27 14:25:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517401, encodeId=fdfa51e401c5, content=即时IF3266/669=4.882，欢迎明年回归5-6分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sun Dec 06 21:51:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485290, encodeId=5d7a485290bf, content=从居稿件，到大修，到小修，到接受，历时一年多，收益很多，不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Nov 04 21:21:00 CST 2011, time=2011-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472906, encodeId=1dd74e2906e7, content=我是试投了一篇关于血脂和amyloidosis方面的文章，写了大约半年。投出去不到3天被拒。估计是可能对amyloid方面不是很感兴趣。拒稿倒是很快。有关与动脉硬化方面的文章还可能试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=744, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老王, createdTime=Fri Dec 10 13:34:00 CST 2010, time=2010-12-10, status=1, ipAttribution=)]

2016-04-27 Lixin Jia

审稿速度:1.0 | 投稿命中率:25.0
经验分享：非常好的杂志但是很难投

358 0

[GetPortalCommentsPageByObjectIdResponse(id=588850, encodeId=724d58885043, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12月初投稿，赶上圣诞但还是在1.7收到一审意见，2个外审评委意见都很好，其中一个给了两个实验建议，另一个评委只指出几处文字问题。2.20一审投回后，两周后即3.5日收到评委的接受回信，给了几处格式修改要求。3.18投回后，3.19正式接受，两周多后4.9号看到文章的在线online。及时三个月多点，取决于一审意见和补实验的周期，AHA.的工作效率是很高的，杂志社也很nice，有问题直接发邮件，都会有回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=734, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45db5217374, createdName=147718f9m15暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578623, encodeId=9b705e86234c, content=审稿速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567501, encodeId=e2cb56e5015c, content=审稿速度非常块，1月就有一审的意见。三个评委提了很多专业问题，给了90天时间修回。二审之快让我吃惊，二周后无任何修改直接接受，然后是二周就出样稿并网站发布。这可以说这几年经历的最快的发表速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555808, encodeId=e1445558080a, content=一般般吧.不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e502075746, createdName=营养医师, createdTime=Mon May 07 19:09:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544291, encodeId=79125442918a, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833201, encodeId=7abf83320174, content=这个杂志不错，投了一篇，给人的感觉就是，专业高效。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Fri Aug 19 10:52:21 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521784, encodeId=b149521e84e0, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常好的杂志但是很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cf91708365, createdName=Lixin Jia, createdTime=Wed Apr 27 14:25:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517401, encodeId=fdfa51e401c5, content=即时IF3266/669=4.882，欢迎明年回归5-6分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sun Dec 06 21:51:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485290, encodeId=5d7a485290bf, content=从居稿件，到大修，到小修，到接受，历时一年多，收益很多，不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Nov 04 21:21:00 CST 2011, time=2011-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472906, encodeId=1dd74e2906e7, content=我是试投了一篇关于血脂和amyloidosis方面的文章，写了大约半年。投出去不到3天被拒。估计是可能对amyloid方面不是很感兴趣。拒稿倒是很快。有关与动脉硬化方面的文章还可能试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=744, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老王, createdTime=Fri Dec 10 13:34:00 CST 2010, time=2010-12-10, status=1, ipAttribution=)]

2015-12-06 ruipinsu

即时IF3266/669=4.882，欢迎明年回归5-6分

387 0

[GetPortalCommentsPageByObjectIdResponse(id=588850, encodeId=724d58885043, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12月初投稿，赶上圣诞但还是在1.7收到一审意见，2个外审评委意见都很好，其中一个给了两个实验建议，另一个评委只指出几处文字问题。2.20一审投回后，两周后即3.5日收到评委的接受回信，给了几处格式修改要求。3.18投回后，3.19正式接受，两周多后4.9号看到文章的在线online。及时三个月多点，取决于一审意见和补实验的周期，AHA.的工作效率是很高的，杂志社也很nice，有问题直接发邮件，都会有回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=734, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45db5217374, createdName=147718f9m15暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578623, encodeId=9b705e86234c, content=审稿速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567501, encodeId=e2cb56e5015c, content=审稿速度非常块，1月就有一审的意见。三个评委提了很多专业问题，给了90天时间修回。二审之快让我吃惊，二周后无任何修改直接接受，然后是二周就出样稿并网站发布。这可以说这几年经历的最快的发表速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555808, encodeId=e1445558080a, content=一般般吧.不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e502075746, createdName=营养医师, createdTime=Mon May 07 19:09:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544291, encodeId=79125442918a, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833201, encodeId=7abf83320174, content=这个杂志不错，投了一篇，给人的感觉就是，专业高效。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Fri Aug 19 10:52:21 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521784, encodeId=b149521e84e0, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常好的杂志但是很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cf91708365, createdName=Lixin Jia, createdTime=Wed Apr 27 14:25:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517401, encodeId=fdfa51e401c5, content=即时IF3266/669=4.882，欢迎明年回归5-6分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sun Dec 06 21:51:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485290, encodeId=5d7a485290bf, content=从居稿件，到大修，到小修，到接受，历时一年多，收益很多，不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Nov 04 21:21:00 CST 2011, time=2011-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472906, encodeId=1dd74e2906e7, content=我是试投了一篇关于血脂和amyloidosis方面的文章，写了大约半年。投出去不到3天被拒。估计是可能对amyloid方面不是很感兴趣。拒稿倒是很快。有关与动脉硬化方面的文章还可能试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=744, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老王, createdTime=Fri Dec 10 13:34:00 CST 2010, time=2010-12-10, status=1, ipAttribution=)]

2011-11-04 匿名用户

从居稿件，到大修，到小修，到接受，历时一年多，收益很多，不错的杂志

447 0

[GetPortalCommentsPageByObjectIdResponse(id=588850, encodeId=724d58885043, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12月初投稿，赶上圣诞但还是在1.7收到一审意见，2个外审评委意见都很好，其中一个给了两个实验建议，另一个评委只指出几处文字问题。2.20一审投回后，两周后即3.5日收到评委的接受回信，给了几处格式修改要求。3.18投回后，3.19正式接受，两周多后4.9号看到文章的在线online。及时三个月多点，取决于一审意见和补实验的周期，AHA.的工作效率是很高的，杂志社也很nice，有问题直接发邮件，都会有回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=734, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45db5217374, createdName=147718f9m15暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578623, encodeId=9b705e86234c, content=审稿速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567501, encodeId=e2cb56e5015c, content=审稿速度非常块，1月就有一审的意见。三个评委提了很多专业问题，给了90天时间修回。二审之快让我吃惊，二周后无任何修改直接接受，然后是二周就出样稿并网站发布。这可以说这几年经历的最快的发表速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555808, encodeId=e1445558080a, content=一般般吧.不难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e502075746, createdName=营养医师, createdTime=Mon May 07 19:09:00 CST 2018, time=2018-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544291, encodeId=79125442918a, content=赚翻了!去年发表了一篇,今年就突破6分,亲们,你们也需要有这样的眼光哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13805560183, createdTime=Sun Jul 16 19:04:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833201, encodeId=7abf83320174, content=这个杂志不错，投了一篇，给人的感觉就是，专业高效。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Fri Aug 19 10:52:21 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521784, encodeId=b149521e84e0, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常好的杂志但是很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cf91708365, createdName=Lixin Jia, createdTime=Wed Apr 27 14:25:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517401, encodeId=fdfa51e401c5, content=即时IF3266/669=4.882，欢迎明年回归5-6分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sun Dec 06 21:51:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485290, encodeId=5d7a485290bf, content=从居稿件，到大修，到小修，到接受，历时一年多，收益很多，不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Nov 04 21:21:00 CST 2011, time=2011-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472906, encodeId=1dd74e2906e7, content=我是试投了一篇关于血脂和amyloidosis方面的文章，写了大约半年。投出去不到3天被拒。估计是可能对amyloid方面不是很感兴趣。拒稿倒是很快。有关与动脉硬化方面的文章还可能试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=744, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=老王, createdTime=Fri Dec 10 13:34:00 CST 2010, time=2010-12-10, status=1, ipAttribution=)]

2010-12-10 老王

我是试投了一篇关于血脂和amyloidosis方面的文章，写了大约半年。投出去不到3天被拒。估计是可能对amyloid方面不是很感兴趣。拒稿倒是很快。有关与动脉硬化方面的文章还可能试试。

744 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务